These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3232130)

  • 1. Long-term effects of ticlopidine on fibrinogen and haemorheology in patients with peripheral arterial disease.
    Palareti G; Poggi M; Torricelli P; Balestra V; Coccheri S
    Thromb Res; 1988 Dec; 52(6):621-9. PubMed ID: 3232130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood viscosity during long-term treatment with ticlopidine in patients with intermittent claudication. A double-blind study.
    Fagher B; Persson S; Persson G; Larsson H
    Angiology; 1993 Apr; 44(4):300-6. PubMed ID: 8457081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Failure of pentoxifylline or cilostazol to improve blood and plasma viscosity, fibrinogen, and erythrocyte deformability in claudication.
    Dawson DL; Zheng Q; Worthy SA; Charles B; Bradley DV
    Angiology; 2002; 53(5):509-20. PubMed ID: 12365857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ticlopidine in the treatment of intermittent claudication: a 21-month double-blind trial.
    Balsano F; Coccheri S; Libretti A; Nenci GG; Catalano M; Fortunato G; Grasselli S; Violi F; Hellemans H; Vanhove P
    J Lab Clin Med; 1989 Jul; 114(1):84-91. PubMed ID: 2661700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ticlopidine lowers plasma fibrinogen in patients with polycythaemia rubra vera and additional thrombotic risk factors. A double-blind controlled study.
    Finelli C; Palareti G; Poggi M; Torricelli P; Vianelli N; Fiacchini M; Zuffa E; Ricci P; Gugliotta L; Coccheri S
    Acta Haematol; 1991; 85(3):113-8. PubMed ID: 2042443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of policosanol and ticlopidine in patients with intermittent claudication: a double-blinded pilot comparative study.
    Castaño G; Más R; Gámez R; Fernández L; Illnait J
    Angiology; 2004; 55(4):361-71. PubMed ID: 15258682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term effects of ticlopidine on lower limb blood flow, ankle/brachial index and symptoms in peripheral arteriosclerosis. A double-blind study. The STIMS Group in Lund. Swedish Ticlopidine Multicenter Study.
    Fagher B
    Angiology; 1994 Sep; 45(9):777-88. PubMed ID: 8092543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of clofibrate on blood viscosity in intermittent claudication.
    Dormandy JA; Gutteridge JM; Hoare E; Dormandy TL
    Br Med J; 1974 Nov; 4(5939):259-62. PubMed ID: 4425853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of ticlopidine on blood fibrinogen and blood viscosity in peripheral atherosclerotic disease.
    Randi ML; Fabris F; Crociani ME; Battocchio F; Girolami A
    Arzneimittelforschung; 1985; 35(12):1847-9. PubMed ID: 4096744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How does ticlopidine treatment lower plasma fibrinogen?
    Mazoyer E; Ripoll L; Boisseau MR; Drouet L
    Thromb Res; 1994 Aug; 75(3):361-70. PubMed ID: 7992249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicenter double-blind study of ticlopidine in the treatment of intermittent claudication and the prevention of its complications.
    Arcan JC; Blanchard J; Boissel JP; Destors JM; Panak E
    Angiology; 1988 Sep; 39(9):802-11. PubMed ID: 3048155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on haematocrit in peripheral arterial disease.
    Lowe GD; Saniabadi A; Turner A; Lieberman P; Pollock J; Drury J
    Klin Wochenschr; 1986 Oct; 64(19):969-74. PubMed ID: 3784449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variability in responsiveness to clopidogrel in patients with intermittent claudication.
    Cassar K; Bachoo P; Ford I; Greaves M; Brittenden J
    Eur J Vasc Endovasc Surg; 2006 Jul; 32(1):71-5. PubMed ID: 16549375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of EMATAP: a double-blind placebo-controlled multicentre trial of ticlopidine in patients with peripheral arterial disease.
    Blanchard J; Carreras LO; Kindermans M
    Nouv Rev Fr Hematol (1978); 1994; 35(6):523-8. PubMed ID: 8152898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of severe intermittent claudication by controlled defibrination.
    Dormandy JA; Goyle KB; Reid HL
    Lancet; 1977 Mar; 1(8012):625-6. PubMed ID: 66429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haemostatic and rheological factors in intermittent claudication: the influence of smoking and extent of arterial disease.
    Lee AJ; Fowkes FG; Rattray A; Rumley A; Lowe GD
    Br J Haematol; 1996 Jan; 92(1):226-30. PubMed ID: 8562400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A controlled trial of pentoxifylline (Trental 400) in intermittent claudication: clinical, haemostatic and rheological effects.
    Reilly DT; Quinton DN; Barrie WW
    N Z Med J; 1987 Jul; 100(828):445-7. PubMed ID: 3330188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined intravenous and oral pentoxifylline in the treatment of peripheral vascular disease. A clinical trial.
    Thomson GJ; Thomson S; Todd AS; Vohra RK; Carr MH; Walker MG
    Int Angiol; 1990; 9(4):266-70. PubMed ID: 2099961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of pain-free treadmill training on fibrinogen, haematocrit, and lipid profile in patients with claudication.
    Mika P; Wilk B; Mika A; Marchewka A; Nizankowski R
    Eur J Cardiovasc Prev Rehabil; 2011 Oct; 18(5):754-60. PubMed ID: 21450630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clopidogrel has no effect on D-dimer and thrombin-antithrombin III levels in patients with peripheral arterial disease undergoing peripheral percutaneous transluminal angioplasty.
    Cassar K; Bachoo P; Ford I; Greaves M; Brittenden J
    J Vasc Surg; 2005 Aug; 42(2):252-8. PubMed ID: 16102623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.